This study was undertaken to determine whether acute phase proteins (APP) induce the synthesis of interleukin 1/8 (IL-1/8) and its specific antagonist, IL-1 receptor antagonist (IL-1Ra), in human peripheral blood mononuclear cells (PBMC). PBMC from healthy volunteers were incubated with C-reactive protein (CRP), oq-antitrypsin (ott-AT), or ott-add glycoprotein (AGP), and the levels of IL-1/8 and IL-1Ra produced were measured by specific radioimmunoassay. To evaluate the effects of c~t-AT further, a synthetic pentapeptide FVYLI corresponding to the minimal binding sequence for the serpine--enzyme complex receptor was also evaluated. PBMC incubated for 24 h with CRP, c~t-AT, or the pentapeptide FVYLI synthesized large quantities of IL-1Ra, 5-10-fold greater than the amount of IL-1B produced by these cells. AGP induced significantly less IL-1Ra than the other APP tested. These effects were shown to be specific, in that polyclonal antibodies against CRP, c~I-AT, and AGP eliminated the cytokine production induced by these respective proteins. CRP, c~vAT, FVYLI, and AGP were synergistic with low concentrations of endotoxin in the induction of both IL-1Ra and IL-1/8 synthesis. We suggest that the preferential induction of IL-1Ra by APP may contribute to their antiinflammatory effects and provide an important regulatory sigrial for the acute phase response.
T
he liver is thought to play a central role in limiting local and systemic inflammation. D-Galactosamine, an hepatocyte-specific inhibitor of RNA and protein synthesis, sensitizes animals to the lethal effects of endotoxin or TNF-ot, suggesting that proteins synthesized in the liver in response to inflammatory mediators attenuate their biological effects (1) . The acute phase response induced by turpentine administration protects mice from D-galactosamine/endotoxin and D-galactosamine/TNF-cr-induced death (2) .
In some instances, specific hepatic acute phase proteins (APP) 1 synthesized in response to infection or tissue injury have been demonstrated to protect animals from various inflammatory insults. For example, transgenic mice expressing rabbit C-reactive protein (CRP) resist endotoxemia (3) . Rabbits with elevated serum CRP induced by croton oil injections exhibit diminished neutrophil infiltration and vascular permeability in a C5a-induced alveolitis model (4) . Serum amyloid A attenuates IL-1-and TNF-ot-induced fever and hypothalamic I Abbreviations used in this paper: AGP, c~t-acid glycoprotein; APP, acute phase protein(s); oq-AT, oq-antitrypsin; CRP, C-reactive protein; IL-2Ra, IL-2 receptor antagonist; SEC, serpine-enzyme complex.
PGE2 synthesis in mice (5) . Both C~l-antitrypsin (oq-AT) and antichymotrypsin inhibit neutrophil superoxide production (6, 7) , which may contribute to the protective effect of otl-AT on the development of bleomycin-induced pulmonary fibrosis (8) . Furthermore otl-AT protects cultured lung endothelial cells from endotoxin injury (9) . The mechanisms by which APP protect against inflammation are generally not understood.
IL-1 plays a key role in inflammatory and growth processes. IL-1 is an important mediator of fever, hypotension, and the acute phase reaction (10) . A specific inhibitor of IL-1 has been identified and its cDNA has been cloned (11) (12) (13) . This inhibitor is closely related to IL-lot and IL-1/8 and competitively blocks the binding of IL-1 to its receptors (12, 13) . This ILl receptor antagonist (IL-1Ra) has no agonist activity (14) and efficiently blocks IL-1 effects both in vitro and in vivo (12, 13) . IL-1Ra has been shown to reduce the severity of sepsis, arthritis, colitis, and other inflammatory processes in several animal models (12, 13) .
In this investigation, we sought to determine whether or not the antiinflammatory effects of certain hepatic APP could be attributed to a modulation in the profile of cytokines pro-PBMC Cultures. PBMC were isolated from the heparinized blood of healthy donors by centrifugation through FicoU Hypaque (Sigma Chemical Co.). The cells were washed three times with sterile PBS and then incubated in polypropylene tubes (5 ml) at a density of 2.5 x 106 cells/ml in 1 ml of RPMI 1640 medium (GIBCO, Grand Island, NY), containing 10 mM Hepes (Sigma Chemical Co.), 2 mM t-glutamine, 100 U/ml penicillin, and 100 /xg/ml streptomycin (Irvine Scientific, Santa Ana, CA). Complete medium was subjected to ultraftltration to remove endotoxin and other cytokine-inducing materials (17) . Polymyxin B (5/xg/ml) was included in all culture medium except that used in experiments with LPS. PBMC were incubated with CR.P, cq-AT, FVYL, FVYLI, AGE or LPS at 37~ in a humidified atmosphere containing 5% CO2 for 24 h unless stated otherwise. PBMC cultures were frozen and thawed three times (18) . The amount of IL-I~ and IIr reported in these experiments therefore represents the total amount (secreted plus cell-associated) generated.
RIAs. Specific RIAs for IL-1Rc~ and IL-1B were used in each study (18, 19) . The threshold of detection for both assays was 80-160 pg/ml.
Statistics. All data are expressed as mean + SEM. Two-tailed paired t tests and analysis of variance (ANOVA) using Fisher's least significant difference were used. P values <0.05 were considered to be significant. of as low as 50/xg/ml CRP induced significantly more IL1Ra (1.9 _+ 0.3 ng/ml) than did control medium (0.35 +_ 0.1 ng/ml) (P <0.05). Induction of IL-1Ra by CRP was concentration dependent and maximal at 300/~g/ml CRP. In contrast, CRP induced IL-lfl only at the highest concentration tested (300 lzg/ml) (P <0.05). The amount of IL-1Ra produced by PBMC at a CRP concentration of 300/xg/ml was nearly 10-fold the amount of IL-1B produced.
We next studied the time course of IL-1Ra and IL-I~ production in response to CRP. A concentration of 300/zg/ml CRP was used in these experiments. Freshly isolated PBMC contained neither measurable IL-1Ra nor IL-1/3. After a 2-h incubation, low levels of IL-1Ra were detectable. Significant amounts of IL-1Ra (1.4 + 0.20 ng/ml) were measurable after a 4 h incubation and peak levels oflL-1Ra (11.8 _+ 1.2 ng/ml) and IL-1B (1.5 + 0.23 ng/ml) were obtained after 24 h (Fig. 2) .
To rule out the possibility that the effects observed with CRP were due to endotoxin contamination, PBMC were incubated with CRP in the presence or absence of an anti-CRP antibody or polymyxin B. As shown in Table 1 , anti-CRP antibodies, but not control antibodies, completely blocked CRP-induced IL-1Ra and IL-1[3 synthesis, whereas LPCinduced IL-1Ra and IL-1B production was not affected. In parallel experiments, polymyxin B (5/~g/ml) completely abolished LPS-induced but not CRP-induced cytokine production (Table 1) .
IL-2 induces both IL-I~ and IL-1Ra in vitro (20, H. Tilg, manuscript submitted for publication). Because the CRP used in our studies was purified from sera obtained from patients undergoing IL-2 treatment, it was essential to demonstrate that our CRP preparation did not contain residual IL-2, which could contribute to the IL-1Ra and IL-1/~ production attributed to CRP. PBMC stimulated with IL-2 or CkP were incubated with an anti-IL-2 or anti-p75 IL-2 receptor IgG and the production of IL-1Ra and IL-I~ measured. Both anti- production by PBMC stimulated with 300 ktg/ml CRP. Data are derived from the cells of three donors and are shown as mean • SEM. *P <0.05; 9 *P <0.005 from t ~ 0.
Results
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bodies completely suppressed IL-2-induced IL-1Ra and IL-1/3 production but did not influence CRP-induced IL-1Ra and IL-13 synthesis (Table 1) .
Induction of IL-IRa and IL-113 in PBMC by crl-AT and FVYLI. Both Oil-AT and FVYLI induced concentration-
dependent IL-1Ra and IL-13 synthesis (Fig. 3) . oq-AT at a concentration of 10-7 M induced significant amounts of IL1Ra (1.9 _+ 0.2 ng/ml), whereas IL-13 production required a higher concentration (10 -6 M) of o~I-AT (Fig. 3 A) . At o~I-AT concentrations of 10-6 and 10-5 M, the induced IL1Ra concentrations were approximately eightfold those of IL-13. The effects of oerAT on IL-1Ra and IL-13 production were almost completely blocked by a specific anti-oct-AT antibody that had no effect on LPS-induced cytokine synthesis (Table 2 ). Despite the fact that c~I-AT is known to bind to the serpin-enzyme complex (SEC) receptor on human monocytes as a complex with elastase (21), the addition of leukocyte elastase did not enhance the inductive effects of otl-AT. In fact, incubation of PBMC with equimolar concentrations of elastase and c~I-AT induced IL-1Ra and IL-13 levels identical to those obtained with aq-AT alone (data not shown).
The synthetic pentapeptide FVYLI, the minimal binding sequence for the SEC receptor (22) , showed a pattern of cytokine induction similar to that of c,I-AT. At a concentration of 10 -6 M, significant amounts of IL-1Ra (1.6 + 0.3 ng/ml) were induced, whereas significant IL-13 production was observed only at 10 -4 M (Fig. 3 B) . 10 -4 M of FVYLI induced as much IL-1Ra and IL-3 as 10 -6 M col-AT. The ratio of IL-IRa to IL-13 was consistently in excess of 5 with each concentration FVYLI tested over 10 -6 M. The control peptide FVYL showed no significant induction of both IL- PBMC were incubated for 24 h. Data represent mean • SEM from three experiments. Polymyxin B was used at a concentration of 5/zg/ml. The goat anti-CR.P antibody and a nonimmune goat IgG were both used at a concentration of 100 #g/ml. The anti-IL-2 antiserum and anti-p75 IL-2 receptor mAb were used at concentrations of 1,000 U/ml and 100/~g/ml, respectively. * P <0.005 from CRP, IL-2, and LPS alone.
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Trig et al. by human PBMC incubated with r (mean _+ SEM; n = 6). *P <0.05; **P <0.005 compared to unstimulated PBMC. (B) Induction of IL-1Ra (wen bars) and Ibl/3 (hatched bars) by the pentapeptide FVYLI in human PBMC (same donors as A) (mean + SEM; n = 6). *P <0.05; **P <0.005 compared to unstimulated PBMC. 1Ra and IL-13; likewise, DMSO at the concentrations used for dissolving the short peptides did not induce cytokine production (data not shown).
Induction of lL-1Ra and IL-lfl by AGP.
We also tested another APE AGP, for its potential to induce IL-1Ra and IL-13. AGP induced significantly less IL-1Ra than CRP or Otr AT (Fig. 4) . In addition, the ratio of IL-1Ra to IL-I~ was only 2.4:1. AGP-induced cytokine production was abrogated with a specific antibody, whereas a control antibody showed no effect ( Table 2 ). The anti-AGP IgG had no effect on LPSinduced IL-1Ra or IL-1B synthesis. with increasing concentrations of CRP and at-AT for 24 h, and the IL-1Ra produced was measured by RIA. Low concentrations of CRP and at-AT, which individually induced only modest amounts of IL-1Ra, were highly stimulatory when present simultaneously (Table 3 ). This synergy was especially evident with 10 -7 M oq-AT, which induced only 0.93 _ 0.03 ng/ml IL-1Ra by itself but 3.27 + 0.35 ng/ml IL-1Ra (P <0.02) in the presence of trivial (10/xg/ml) concentrations of CRP.
Synergistic Effects of CRP and cerAT on the Synthesis of lLIRa by PBMC. PBMC from three donors were incubated
Synergistic Effects of CRP, a1-AT, FVYLI, and AGP with LPS on IL-1Ra and IL-lfl Synthesis by PBMC. PBMC were
incubated with increasing concentrations of LPS and either 50/zg/ml CRP, 10 -7 M otrAT, 10 -6 M FVYLI, or 100 /xg/ml AGE LPS induced comparable amounts of IL-1Ra and IL-1/~ (Figs. 5 and 6). Each APP tested as well as the peptide FVYLI were synergistic with low concentrations (10 pg/ml) of LPS in the induction of IL-1Ra (Fig. 5 ) and IL-1/~/ (Fig.  6 ). PBMC incubated with LPS (10 pg/ml) plus APP synthesized significantly more IL-1Ra and IL-I~ than with LPS alone (P <0.001 for each APP tested). DMSO at concentrations used to dissolve FVYLI had no effect on LPS-induced IL-1Ra and IL-1B synthesis (data not shown).
Discussion
Several hepatic APP have been shown to either induce or augment the synthesis of IL-1, TNF, and IL-6 in vitro (23) (24) (25) , suggesting that APP contribute to the development of an inflammatory response. Despite these in vitro data, several animal models exist in which the prior initiation of an acute phase response or the administration of a specific APP have been shown to limit the severity of inflammation or to protect against the lethal effects of LPS, TNF, or IL-1 (2-9). The mechanism underlying these antiinflammatory effects is unclear.
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Interleukin 1 Receptor Antagonist Induction by Acute Phase Proteins CR, P has been shown to induce the synthesis of IL-lot, IL-I~, TNFot, and IL-6 in human PBMC and alveolar macrophages (23, 24) , suggesting that one of its primary functions is the amplification of inflammatory responses. However, our studies demonstrate that CRP is, in fact, a more potent inducer of the antagonist IL-1Ra. In this respect, the synthetic response to CRP more closely resembles the response to immune complexes or aggregated IgG than the response to LPS or IL-2, both of which induce approximately equal amounts of IL-1Ra and IL-I~/( Table 1 ). The conten- tion that CRP is primarily an antiinflammatory mediator is supported by data from animal studies in which high serum levels of CRP resulting either from prior turpentine treatment or as a result of the expression of a transgene protect mice from lethal doses of LPS (2, 3) . The morbidity associated with sepsis is thought to be due to endogenous plateletactivating factor, a phosphorylcholine-containing phospholipid (26) . As suggested by Xia et al. (3, 27) , the binding of platelet-activating factor through its phosphorylcholine moiety may indeed be an important mechanism underlying the protective effect of CRP. However, several studies have shown that IL-1Ra exerts a similar protective effect in LPStreated animals and it is therefore equally plausible that the induction of IL-1Ra is the primary mechanism by which CRP mediates its protective effects (12, 13, 28) .
Effect of Specific Antibodies on cr,-AT-and AGP-induced IL-IRa and IL-I~ Synthesis
The hepatic APP 0/1-AT is a member of the serine protease inhibitor (serpin) family. 0/1-AT is, in fact, the major circulating inhibitor of neutrophil elastase and a deficiency of this inhibitor is associated with chronic inflammation in the lung and liver with premature emphysema and cirrhosis (29) . 0/1-AT-elastase complexes are known to bind to SEC receptors present on hepatocytes, the result of which is the up-regulation of 0/1-AT synthesis in the liver (21) . A similar receptor has been described on neutrophils and its engagement results in chemotaxis (30) . We have shown that stimulation of PBMC with prepared 0/1-AT-elastase complexes, 0/1-AT alone, or the pentapeptide FVYLI induces the preferential synthesis of IL-1Ra, presumably a result of signaling through the SEC receptor or a related structure. The activity of 0/1-AT in the absence of exogenous elastase is most likely due to the formation of a complex with endogenous elastase (31) .
SEC receptors are involved in the clearance of several distinct SECs including thrombin-antithrombin III, thrombinheparin cofactor II, as well as 0/1-AT-elastase (32). Our results suggest that SEC receptors not only remove endogenous proteases such as elastase from the circulation but may trigger the generation of an important IL-1 antagonist. The development of pulmonary fibrosis in response to the chemotherapeutic agent bleomycin is largely due to endogenous IL-1 and can be prevented by the administration of IL-1Ra or o/l-AT (8, 33) . The role of IL-1 in tissue fibrosis and the ability of SECs to stimulate IL-1Ra synthesis suggest that the cir- 1634 Interleukin 1 Receptor Antagonist Induction by Acute Phase Proteins rhosis associated with c~I-AT deficiency may not be entirely due to inadequate clearance of elastase but also to reduced IL-1Ra synthesis. AGP is another hepatic APP implicated in the regulation of inflammation. AGP undergoes extensive posttranslational modification, including the acquisition of sialyl-Lewis-X containing glycans during an acute phase response (34) . The expression of the sialyl-Lewis-X epitope may allow AGP to bind to selectins present on leukocytes and endothelial cells. Such an interaction might interfere with leukocyte emigration and thereby suppress inflammation (34) . Although AGP is known to potentiate LPS-induced secretion of proinflammatory cytokines by human monocytes (25) , it also induces the production of an IL-1 inhibitor by murine macrophages (35) . The induction of this inhibitor appears to depend on the extent of glycosylation (35) . Our studies strongly suggest that this IL-1 inhibitor is IL-1Ra. The AGP preparation used in our investigation was not as potent an inducer of IL-1Ra as CR.P or c~t-AT. However, we have not surveyed a wide range of AGP preparations, in particular material isolated from sera of patients with inflammatory diseases. It is conceivable that the weak response to our AGP preparation could be due to inadequate glycosylation.
We have shown that three distinct, structurally unrelated APP are potent inducers of the antiinflammatory cytokine IL-1Ra and have suggested that these inductive effects may account for some of their antiinflammatory properties. These same agents, however, are highly synergistic with low concentrations of LPS in inducing the synthesis of both IL-I~ and IL-1Ra. In fact, the relative amounts of IL-1Ra and IL-18 generated in response to the APP/LPS combination are similar to those induced by high concentrations of LPS alone. These findings indicate that APP may function in a dual role, amplifying inflammatory responses when the inciting pathogen is present within the host and down-modulating the response when the pathogen has been eradicated. Our results suggest that modulation of the profile of cytokines generated under different circumstances may be the means by which such a dual function is achieved.
